Distinct Nasopharyngeal and Oropharyngeal Microbiota of Children with Influenza A Virus Compared with Healthy Children

BioMed Research International

Volumn 2018, Issue , 2018, Pages

  Wen, Zhixin ^a   Xie, Gan ^a   Zhou, Qian ^b   Qiu, Chuangzhao ^b   Li, Jing ^a   Hu, Qian ^a   Dai, Wenkui ^b   Li, Dongfang ^b   Zheng, Yuejie ^a   Wen, Feiqiu ^a  

^a SHENZHEN CHILDREN'S HOSPITAL   (China)

^b WeHealthGene Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 16S; BACTERIAL DNA; RNA 16S;

ABIOTROPHIA; ACIDOBACTERIA; ACTINOMYCES; ARTICLE; ATOPOBIUM; BACILLUS; BIFIDOBACTERIUM; BLAUTIA; CARDIOBACTERIUM; CHILD; CONTROLLED STUDY; CORYNEBACTERIUM; CRONOBACTER; DISEASE SEVERITY; DNA SEQUENCE; DOLOSIGRANULUM; EUBACTERIUM; FEMALE; FIRMICUTES; FUSOBACTERIUM; GEMELLA; GRANULICATELLA; HAEMOPHILUS; HALOMONAS; HUMAN; INFANT; INFLUENZA A; LACHNOCLOSTRIDIUM; LACTOBACILLUS; LACTOCOCCUS; LEPTOTRICHIA; MAJOR CLINICAL STUDY; MALE; MICROFLORA; MORAXELLA; NASOPHARYNX; NEISSERIA; NONHUMAN; OROPHARYNX; PHYLLOBACTERIUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVOTELLA; PSEUDOMONAS; RALSTONIA; RUMINOCOCCUS; SCHOOL CHILD; SPHINGOMONAS; STAPHYLOCOCCUS; STREPTOCOCCUS; VEILLONELLA; ZOOGLOEA; ADOLESCENT; BACTERIUM; GENETICS; INFLUENZA; INFLUENZA A VIRUS; MICROBIOLOGY; NEWBORN; PATHOGENICITY; VIROLOGY;

ADOLESCENT; BACTERIA; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MICROBIOTA; NASOPHARYNX; OROPHARYNX; RNA, RIBOSOMAL, 16S;

EID: 85058338127     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2018/6362716     Document Type: Article

References (47)

1. J. S. Bradley, C. L. Byington, S. S. Shah et al., "Themanagement of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America," Clinical Infectious Diseases, vol. 53, no. 7, pp. e25-e76, 2011.
2. J. Artois, H. Jiang, X. Wang et al., "Changing geographic patterns and risk factors for avian influenza A(H7N9) infections in humans, China," Emerging Infectious Diseases, vol. 24, no. 1, pp. 87-94, 2018.
3. "Recommendations for Prevention and Control of Influenza in Children, 2017 - 2018," Pediatrics, vol. 140, no. 4, p. e20172550, 2017.
4. X. Gong, H. Yin, Y. Shi et al., "Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B," Emerging microbes & infections, vol. 5, p. e51, 2016.
5. S. Zou, R. Gao, Y. Zhang et al., "Molecular characterization of H6 subtype influenza viruses in southern China from 2009 to 2011," Emerging microbes & infections, vol. 5, no. 7, p. e73, 2016.
6. E. J. A. Schrauwen and R. A. M. Fouchier, "Host adaptation and transmission of influenzaA viruses in mammals," Emerging Microbes and Infections, vol. 3, 2014.
7. R. K.-K. Leung, J.-W. Zhou, W. Guan, S.-K. Li, Z.-F. Yang, and S. K.-W. Tsui, "Modulation of potential respiratory pathogens by pH1N1 viral infection," Clinical Microbiology and Infection, vol. 19, no. 10, pp. 930-935, 2013.
8. B. Chaban, A. Albert, M. G. Links et al., "Characterization of the Upper Respiratory Tract Microbiomes of Patients with Pandemic H1N1 Influenza," PLoS ONE, vol. 8, no. 7, p. e69559, 2013.
9. H. Lu, A. Li, T. Zhang et al., "Disordered oropharyngealmicrobial communities in H7N9 patients with or without secondary bacterial lung infection," Emerging Microbes & Infections, vol. 6, no. 12, p. e112, 2017.
10. A. L. Greninger, E. C. Chen, T. Sittler et al., "A Metagenomic Analysis of Pandemic Influenza A (2009 H1N1) Infection in Patients from North America," PLoS ONE, vol. 5, no. 10, p. e13381, 2010.
11. A. Sahin-Yilmaz and R. M. Naclerio, "Anatomy and physiology of the upper airway," Proceedings of the American Thoracic Society, vol. 8, no. 1, pp. 31-39, 2011.
12. P.G. Holt, D.H. Strickland, M. E. Wikström, and F. L. Jahnsen, "Regulation of immunological homeostasis in the respiratory tract," Nature Reviews Immunology, vol. 8, no. 2, pp. 142-152, 2008.
13. T. J. Braciale, J. Sun, and T. S. Kim, "Regulating the adaptive immune response to respiratory virus infection," Nature Reviews Immunology, vol. 12, no. 4, pp. 295-305, 2012.
14. S. V. Lynch, "Viruses andmicrobiome alterations," Annals of the AmericanThoracic Society, vol. 11, no. 1, pp. S57-S60, 2014.
15. J. C. Brealey, P. D. Sly, P. R. Young, and K. J. Chappell, "Viral bacterial co-infection of the respiratory tract during early childhood," FEMS Microbiology Letters, vol. 362, no. 10, 2015.
16. W. A. A. De Steenhuijsen Piters, E. G.W. Huijskens, A. L. Wyllie et al., "Dysbiosis of upper respiratory tractmicrobiota in elderly pneumonia patients, "TheISME Journal, vol. 10, no. 1, pp. 97-108, 2016.
17. O. Sakwinska, V. B. Schmid, B. Berger et al., "Nasopharyngeal microbiota in healthy children and pneumonia patients," Journal of Clinical Microbiology, vol. 52, no. 5, pp. 1590-1594, 2014.
18. Z. Lu, W. Dai, Y. Liu et al., "The alteration of nasopharyngeal and oropharyngeal microbiota in children with MPP and non- MPP," Gene, vol. 8, no. 12, 2017.
19. S. Bousbia, L. Papazian, P. Saux et al., "Repertoire of Intensive Care Unit Pneumonia Microbiota," PLoS ONE, vol. 7, no. 2, p. e32486, 2012.
20. A. A. T. M. Bosch, E. Levin, M. A. van Houten et al., "Development of upper respiratory tractmicrobiota in infancy is affected by mode of delivery," EBioMedicine, vol. 9, pp. 336-345, 2016.
21. K. Hasegawa, J. M. Mansbach, N. J. Ajami et al., "Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis," European Respiratory Journal, vol. 48, no. 5, pp. 1329-1339, 2016.
22. Q. Hu, W. Dai, Q. Zhou et al., "Dynamic oropharyngeal and faecal microbiota during treatment in infants hospitalized for bronchiolitis compared with age-matched healthy subjects," Scientific Reports, vol. 7, no. 1, 2017.
23. A. Rynda-Apple, K. M. Robinson, and J. F. Alcorn, "Influenza and bacterial superinfection: Illuminating the immunologic mechanisms of disease," Infection and Immunity, vol. 83, no. 10, pp. 3764-3770, 2015.
24. Heping Wang, Wenkui Dai, Xin Feng et al., "Microbiota Composition in Upper Respiratory Tracts of Healthy Children in Shenzhen, China, Differed with Respiratory Sites and Ages," BioMed Research International, vol. 2018, Article ID 6515670, 8 pages, 2018.
25. M. M. Pettigrew, J. F. Gent, Y. Kong et al., "Association of sputum microbiota profiles with severity of community-acquired pneumonia in children," BMC Infectious Diseases, vol. 16, no. 1, 2016.
26. S. M. Teo, D. Mok, K. Pham et al., "The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development," Cell Host &Microbe, vol. 17, no. 5, pp. 704-715, 2015.
27. J. J. Kozich, S. L. Westcott, N. T. Baxter, S. K. Highlander, and P. D. Schloss, "Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform," Applied and Environmental Microbiology, vol. 79, no. 17, pp. 5112-5120, 2013.
28. J. G. Caporaso, J. Kuczynski, J. Stombaugh et al., "QIIME allows analysis of high-throughput community sequencing data," Nature Methods, vol. 7, no. 5, pp. 335-336, 2010.
29. H. Wang, W. Dai, C. Qiu et al., "Mycoplasma pneumoniae and Streptococcus pneumoniae caused differentmicrobial structure and correlation network in lungmicrobiota," Journal of Thoracic Disease, vol. 8, no. 6, pp. 1316-1322, 2016.
30. I. Letunic and P. Bork, "Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees," Nucleic Acids Research, vol. 44, no. 1, pp. W242- W245, 2016.
31. S. Subramanian, S. Huq, T. Yatsunenko et al., "Persistent gut microbiota immaturity in malnourished Bangladeshi children," Nature, vol. 510, no. 7505, pp. 417-421, 2014.
32. W. A. de Steenhuijsen Piters, E. A. Sanders, and D. Bogaert, "The role of the local microbial ecosystem in respiratory health and disease," Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 370, no. 1675, 2015.
33. E. S. Gollwitzer and B. J. Marsland, "Impact of Early-Life Exposures on Immune Maturation and Susceptibility to Disease," Trends in Immunology, vol. 36, no. 11, pp. 684-696, 2015.
34. G. Biesbroek, E. Tsivtsivadze, E. A. M. Sanders et al., "Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children," American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 11, pp. 1283-1292, 2014.
35. S. J. Siegel, A.M. Roche, and J. N. Weiser, "Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source," Cell Host & Microbe, vol. 16, no. 1, pp. 55-67, 2014.
36. M. Yan, S. J. Pamp, J. Fukuyama et al., "Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage," Cell Host &Microbe, vol. 14, no. 6, pp. 631-640, 2013.
37. I. Arnit, M. Garber, N. Chevrier et al., "Unbiasedreconstruction of a mammalian transcriptional network mediating pathogen responses," Science, vol. 326, no. 5950, pp. 257-263, 2009.
38. N. Chevrier, P. Mertins, M. N. Artyomov et al., "Systematic discovery of TLRsignaling components delineates viral-sensing circuits," Cell, vol. 147, no. 4, pp. 853-867, 2011.
39. C.M. Bassis, J. R. Erb-Downward, R. P. Dickson et al., "Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals," mBio, vol. 6, no. 2, Article ID e00037-15, 2015.
40. E. S. Charlson, K. Bittinger, A. R. Haas et al., "Topographical continuity of bacterial populations in the healthy human respiratory tract," American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 8, pp. 957-963, 2011.
41. C. Bellinghausen, G. G. U. Rohde, P. H.M. Savelkoul, E. F.M. Wouters, and F. R. M. Stassen, "Viral-bacterial interactions in the respiratory tract," Journal of General Virology, vol. 97, no. 12, pp. 3089-3102, 2016.
42. M. M. Pettigrew, A. S. Laufer, J. F. Gent, Y. Kong, K. P. Fennie, and J. P. Metlay, "Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children," Applied and Environmental Microbiology, vol. 78, no. 17, pp. 6262-6270, 2012.
43. S. Nakamura, K. M. Davis, and J. N. Weiser, "Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization inmice, "The Journal of Clinical Investigation, vol. 121, no. 9, pp. 3657-3665, 2011.
44. E. T. Zemanick, B. D. Wagner, C. E. Robertson et al., "Airway microbiota across age and disease spectrum in cystic fibrosis," European Respiratory Journal, vol. 50, no. 5, p. 1700832, 2017.
45. P. N. Luna, K. Hasegawa, N. J. Ajami et al., "The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis," Microbiome, vol. 6, no. 1, 2018.
46. C. J. Heneghan, I. Onakpoya, M. A. Jones et al., "Neuraminidase inhibitors for influenza: A systematic review and meta-analysis of regulatory andmortality data, "Health Technology Assessment, vol. 20, no. 42, pp. 1-242, 2016.
47. M. E. Bonomo and M. W. Deem, Predicting influenza h3n2 vaccine efficacy from evolution of the dominant epitope, Clin Infect Dis, no, vol, 2018.